M NE 200 (Nevirapine 200 mg)

Pill imprint M NE 200 has been identified as Nevirapine 200 mg.

Nevirapine is used in the treatment of reduction of perinatal transmission of hiv; hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Nevirapine

Imprint:

M NE 200

Strength:

200 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

NNRTIs

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.